Pathomechanisms underlying sleep dysfunction in MCI and AD patients are mostly unknown, though AD-related pathological proteins, such as Aβ- and tau- oligomers are known to disrupt sleep but their mode of action is unknown. The gene discussed is MAPT; the disease is Alzheimer disease.